Delivery Order SPE2D020D0009-SPE2D324F286X

Award Date 9/24/24
Potential Completion Date 9/27/24
Potential Value $85K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the supply of doxycycline hydrochloride injection (10) at a ceiling value of $3,333.06. The contract has a firm fixed price pricing type and an ultimate completion date of September 27, 2024. This delivery order is not set aside and is part of Fresenius Kabi's broader indefinite delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4553868921 Doxycycline Hydrochloride Injection (10) to support military medical facilities. The contract has a firm fixed price of $87,201.17 and a completion date of June 18, 2021. Fresenius Kabi, LLC is a significant supplier of critical care...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of DOXYCYCLINE HYDROCHLORIDE INJECTION (10), a critical care medication, to military medical facilities worldwide. The contract has a ceiling value of $79,808.27 and is a firm fixed-price, non-set-aside delivery order with a completion date of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $85,527.80, is for the delivery of Doxycycline Hydrochloride Injection (10) to support military medical facilities worldwide. The contract is structured as a delivery order with a firm fixed price and does not have a set-aside designation. Fresenius Kabi is a...
This contract award to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company, provides for the delivery of doxycycline hydrochloride injection products to the Defense Logistics Agency Troop Support Medical. The $373,741.40 firm fixed price delivery order contract was awarded on September 26, 2019 with a completion date of October 1, 2019. This award is not associated with a set-aside program. Fresenius Kabi has received over $1.8 million in previous prime federal contracts,...
This federal contract award, identified as SPE2D020D0009|SPE2D324F287B, was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection (10) and has a ceiling value of $53,143.79. The contract is structured as a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 27, 2024. Fresenius...
This federal contract award, SPE2D020D0009|SPE2D324F286Z, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $110,176.15 firm fixed-price delivery order is for the supply of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical, with a completion date of September 27, 2024. Fresenius Kabi, LLC is a major supplier of injectable...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of various generic injectable pharmaceutical products, including medications like ketorolac, furosemide, lidocaine, diphenhydramine, and atropine, to support the medical supply needs of military facilities worldwide. The contract has a ceiling value of $1,257,405.54 and a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,338,659 units of Doxycycline Hyclate 100 mg tablets, a generic antibiotic medication, with a ceiling value of $2,551.68. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 24, 2025. This contract is not designated as a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of doxycycline 25 mg/5 ml suspension. The contract is a firm fixed-price delivery order with a ceiling value of $2,243.74 and a performance period extending through June 18, 2025. The contract is not set aside and is awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D324F286X
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, for the supply of Doxycycline Hydrochloride Injection (10). The contract has a firm fixed price of $84,622.69 and a period of performance through September 27, 2024. This contract is not set-aside and is part of a larger indefinite delivery contract (IDV) that Fresenius Kabi holds with the Department of Veterans Affairs National Acquisition Center for the supply of cancer treatment drug Bortezomib. The Fresenius Kabi IDV with the VA is valued at $2.24 million over five years, demonstrating the company's capability to secure both small delivery orders and substantial long-term contracts to provide critical medications to federal healthcare agencies, including the Department of Defense.

Generated 12/24/24, 9:22 AM